News Xlife Sciences AG

Equities

XLS

CH0461929603

Delayed Swiss Exchange Other stock markets 11:31:57 2024-04-25 am EDT			5-day change	1st Jan Change
34.3 ^CHF	-0.29%		+0.29%	-31.26%

Apr. 23	Xlife Sciences Posts Higher FY23 Profit; Revenue Falls	MT
Feb. 29	Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xlife Sciences Posts Higher FY23 Profit; Revenue Falls	Apr. 23	MT
Xlife Sciences AG Publishes 2023 Annual Report	Apr. 23	EQ
Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland	Apr. 03	EQ
Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Switzerland’s Xlife Sciences, Abu Dhabi Expand Existing Life Sciences Partnership	Feb. 05	MT
Xlife Sciences AG Expands Collaboration with Department of Health Abu Dhabi, Partners with Thermo Fisher Scientific and Masdar City	Feb. 05	EQ
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline	Dec. 29	EQ
Xlife Sciences AG Achieves Significant Milestone in the Development of Radiodiagnostics for Liver Diseases	Dec. 22	EQ
Xlife Sciences, Quant Team Up to Develop Biomarkers for Kidney Diseases Detection	Dec. 20	MT
Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases	Dec. 20	EQ
Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration	Dec. 18	EQ
Xlife Sciences to Sell Portfolio Company to 4D Lifetec	23-10-18	MT
Successful exit of portfolio company and major invest in AI and digital health in early cancer detection, valued at CHF 23.3 million	23-10-18	EQ
Xlife Sciences AG acquired 20% stake in 4D Lifetec AG for CHF 23.3 million.	23-10-17	CI
ESG Report shows status quo and outlines path for future sustainability improvements Media Release Zurich, September 29, 2023	23-09-29	EQ
Xlife Sciences Loss Narrows in H1; Revenue Declines	23-09-21	MT
Xlife Sciences with significant progress in H1 2023	23-09-21	EQ
Xlife Sciences AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20	CI
Collaboration of Xlife Sciences and the Department of Health – Abu Dhabi to drive global innovations in the life sciences sector	23-08-17	EQ
Xlife Sciences AG Signs Memorandum of Understanding with the Regulator of the Healthcare Sector in the UAE, the Department of Health - Abu Dhabi	23-08-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Xlife Sciences AG

Equities

XLS

CH0461929603

Summary

Filters